Triazole derivative of 2, 4-dihydroxy-5-methyl-acetophenone and application thereof
By developing triazole derivatives of 2,4-dihydroxy-5-methyl-acetophenone in combination with other insecticides, existing insecticides and fungicides have not been effective in preventing and controlling specific plant pathogens and insect pests. The best problem has achieved efficient inhibition and insecticidal effects on a variety of bacteria and insecticides.
Patent Information
- Application Number
- CN202410944914.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-15
AI Technical Summary
Existing insecticides and fungicides have limited effects in preventing and treating plant pathogens and insecticides, especially in the treatment of potato dry rot bacteria, apple rot bacteria, apple anthrax bacteria, tomato gray mold bacteria and rice blast bacteria. The problem of insufficient suppression rate of etc.
The triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone was developed, and used in combination with other insecticidal acaricides such as pyramine, bromopronil, ethiazole, and zosterite. , improves the effects of sterilization and insecticidal.
It has achieved efficient inhibition of dried potato rot bacteria, apple rot bacteria, apple anthrax bacteria, tomato grey mold bacteria and rice blast bacteria, especially the compounds 4c and 5c at a concentration of 50.0 mg/L The inhibition rate reached 90.44% to 96.23%, and showed high insecticidal activity against aphids, clams, diamondback moths and cotton bollworms.
Smart Images

Figure CN118908904A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of natural product pesticides and relates to triazole derivatives of 2,4-dihydroxy-5-methyl-acetophenone and applications thereof, specifically to acetophenone A triazole derivatives and applications thereof in preparing fungicides and / or insecticides. Background Art
[0002] The natural product acetophenone A, full name 2,4-dihydroxy-5-methyl-acetophenone, is a fungal polyketide metabolite natural product with multiple biological activities, such as anti-plant pathogenic fungi, anti-cancer, antioxidant activity, etc. (Patent, application number: CN201410177356.2, CN201910450601.5; Bioorganic & Medicinal Chemistry, 26 (2018), 386–39.)
[0003] Triazole is an important nitrogen heterocycle and is widely present in different bioactive molecules. At the same time, triazole compounds also have many other advantages, such as good stability, high internal absorption rate and low cytotoxicity. Due to the importance of triazole, it has attracted widespread attention from medicinal chemists and has been widely used in the design of new biological and medical preparations. Summary of the invention
[0004] The purpose of the present invention is to provide triazole derivatives of 2,4-dihydroxy-5-methyl-acetophenone and applications thereof. The triazole derivatives of acetophenone A are a new class of compounds and exhibit good plant pathogenic fungus activity and insecticidal activity.
[0005] In order to achieve the above object, the technical solution adopted by the present invention includes:
[0006] A triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone, wherein the derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof;
[0007]
[0008] Wherein, R in Formula I and Formula II 1 One selected from methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen;
[0009] R in Formula I and Formula II 2One selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms, methyl substituted by nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by oxygen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by sulfur-containing heterocycle containing 2-10 carbon atoms, and the aforementioned acyl groups with different substitutions;
[0010] The substituents of the substituted phenyl and substituted benzyl are each independently selected from one or more of hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon, C1-C6 alkoxy, C1-C6 alkylamino, dioxymethylene and dioxyethylene;
[0011] R in Formula I and Formula II 1 is hydrogen, R in Formula I and Formula II 2 The present invention is selected from substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms, methyl substituted by nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by oxygen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by sulfur-containing heterocycle containing 2-10 carbon atoms and the aforementioned acyl groups with different substitutions; the substituents of the substituted phenyl and substituted benzyl are each independently selected from one or more of hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, dioxymethylene group and dioxyethylene group.
[0012] Optionally, the derivative is one of the compounds shown in the following formula:
[0013]
[0014]
[0015]
[0016] A triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone, wherein the derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof;
[0017]
[0018] Wherein, R 1 One selected from methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen;
[0019] R 2 One or more selected from the group consisting of hydrogen, hydroxy, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkylamino group, dioxymethylene and dioxyethylene.
[0020] The invention provides any triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone and use of 2,4-dihydroxy-5-methyl-acetophenone in preparing insecticides.
[0021] Optionally, the insecticide is used to control at least one of aphids, armyworms, diamondback moths and cotton bollworms.
[0022] The invention provides an application of any triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone in the preparation of a fungicide.
[0023] Optionally, the fungicide is used to control at least one of potato dry rot pathogen F.solani, apple rot pathogen Cytospora sp., apple anthracnose pathogen C.gloeosporioides, tomato gray mold pathogen B.cinerea, wheat fusarium rust pathogen F.graminearum and rice blast pathogen M.grisea.
[0024] Advantages of the present invention include:
[0025] The present invention first discovered that the natural product acetophenone A has good insecticidal activity, and on this basis provides a preparation method of acetophenone A triazole derivatives and their application in controlling plant pathogens and killing insects. The acetophenone A triazole derivatives of the present invention exhibit good plant pathogenic bacteria activity and insecticidal activity.
[0026] The compounds of the general formula of the present invention can be used directly as insecticides and fungicides, or can be used with agriculturally acceptable carriers, or can be used in combination with other insecticides, acaricides and fungicides such as tebufenpyrad, chlorfenapyr, etoxazole, cypermethrin, etc. Some of these compositions show synergistic effects, while others show additive effects. DETAILED DESCRIPTION
[0027] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0028] The acetophenone A and its triazole derivatives of the present invention are compounds having the following structure or pharmaceutically acceptable salts thereof:
[0029]
[0030] The acetophenone A triazole derivatives of the present invention are compounds having the structures shown in the following general formulae III and IV or pharmaceutically acceptable salts thereof:
[0031]
[0032] Wherein, R 1 is selected from hydrogen, methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen; R 2 The present invention is selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms, methyl substituted by nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by oxygen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by sulfur-containing heterocycle containing 2-10 carbon atoms and the aforementioned substituted acyl groups; the substituents of the substituted phenyl and substituted benzyl are each independently selected from one or more of hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino, dioxymethylene and dioxyethylene.
[0033] In the present invention, specific examples of C1-C10 alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, and the like.
[0034] The C1-C6 hydrocarbon group can be selected from the specific examples of the above-mentioned alkyl groups and satisfy the corresponding limitations.
[0035] The C1-C6 alkylamino group may be an alkylamino group formed by the above-mentioned specific examples of the alkyl group satisfying the limitation of 1 to 6 carbon atoms.
[0036] The C1-C6 alkoxy group may be an alkoxy group formed by the above-mentioned specific examples of the alkyl group satisfying the limitation of 1 to 6 carbon atoms.
[0037] The nitrogen-containing heterocycle containing 2 to 10 carbon atoms may be an unsaturated nitrogen heterocycle or a saturated nitrogen heterocycle, as long as the nitrogen in the ring structure of the heterocycle is a structural atom and the number of carbon atoms in the heterocycle is 2 to 10, for example, it may be unsubstituted or C1-C6 alkyl-substituted pyrrole, unsubstituted or C1-C6 alkyl-substituted hydropyrrole, unsubstituted or C1-C7 alkyl-substituted imidazole, unsubstituted or C1-C7 alkyl-substituted hydroimidazole, unsubstituted Or C1-C5 alkyl-substituted pyridine, unsubstituted or C1-C5 alkyl-substituted hydrogenated pyridine, unsubstituted or C1-C7 alkyl-substituted pyrazole, unsubstituted or C1-C7 alkyl-substituted hydrogenated pyrazole, unsubstituted or C1-C7 alkyl-substituted thiazole, unsubstituted or C1-C7 alkyl-substituted hydrogenated thiazole, unsubstituted or C1-C7 alkyl-substituted oxazole, unsubstituted or C1-C7 alkyl-substituted hydrogenated oxazole, etc. Wherein, the alkyl group as a substituent can be selected from the specific examples of alkyl groups described above, and the substitution of these alkyl groups can be single-point or multi-point substitution, and the present invention has no particular limitation on this.
[0038] The oxygen-containing heterocycle containing 2-10 carbon atoms may be an unsaturated oxygen heterocycle or a saturated oxygen heterocycle, as long as the ring structure of the heterocycle uses oxygen as a structural atom and the number of carbon atoms in the heterocycle is 2-10, for example, it may be unsubstituted or C1-C6 alkyl-substituted furan, unsubstituted or C1-C6 alkyl-substituted hydrogenated furan, unsubstituted or C1-C7 alkyl-substituted oxazole, unsubstituted or C1-C7 alkyl-substituted hydrogenated oxazole, unsubstituted or C1-C3 alkyl-substituted 1,3-benzodioxole, unsubstituted or C1-C2 alkyl-substituted 1,4-benzodioxole, etc.
[0039] The sulfur-containing heterocycle containing 2-10 carbon atoms can be an unsaturated sulfur heterocycle or a saturated sulfur heterocycle, as long as the ring structure of the heterocycle uses sulfur as a structural atom and the number of carbon atoms in the heterocycle is 2-10. For example, it can be unsubstituted or C1-C6 alkyl-substituted thiophene, unsubstituted or C1-C6 alkyl-substituted hydrothiophene, unsubstituted or C1-C7 alkyl-substituted thiazole, unsubstituted or C1-C7 alkyl-substituted hydrothiazole, etc.
[0040] Wherein, R 1 is selected from methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen; R 2 One or more selected from hydrogen, hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkylamino group, dioxymethylene and dioxyethylene.
[0041] Preferably, R 1 is selected from methyl; R 2 Selected from methyl, benzyl, 4-trifluoromethylbenzyl, 2-bromo-4-methoxybenzyl, 3-bromobenzyl, phenyl, 3-methyl-4-bromophenyl, 3-nitrophenyl, 3,5-difluorophenyl, 3,5-dichlorophenyl.
[0042] In a preferred embodiment of the present invention, the compound represented by the general formula is selected from one of the compounds represented by the following formulae:
[0043]
[0044]
[0045]
[0046] The invention provides a method for preparing the above-mentioned acetophenone A triazole derivative, which comprises: firstly, 1,3-resorcinol and halogenated benzene or halogenated nitrogen-containing heterocycle, halogenated oxygen-containing heterocycle, or halogenated oxygen-containing heterocycle undergoes a substitution reaction under the catalysis of cuprous iodide / N,N-dimethylglycine to generate an intermediate 2b; compound 1 and intermediate 2b undergo acetylation under the action of acetic anhydride to generate intermediates 2a and 3c respectively; 2a reacts with a halogenated hydrocarbon under alkaline conditions to generate intermediate 3a; 2a and a substituted carboxylic acid undergo esterification under the action of DCC / DMAP to generate intermediate 3b.
[0047]
[0048] Intermediate 3 is successively brominated with copper bromide, and further substituted with N-amino-1,2,4-oxazole to generate target product 4 (I and III); 4 (I and III) is further reacted with nitrous acid to generate target product 5 (II and IV).
[0049]
[0050] Among them, R 1 , R 2 As described above, the present invention will not be described in detail here.
[0051] In order to obtain compounds with higher fungicidal and insecticidal activity, the acetophenone triazole derivatives of the present invention are preferably selected from one or more of the following compounds:
[0052] 1H-1-(2'-(2"-hydroxy-4"-methoxy-5"methylphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4a);
[0053] 1H-1-(2'-(2"-hydroxy-4"-(4"'-trifluoromethylbenzyl)oxy-5"-methylphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4c);
[0054] 1-(2'-Hydroxy-4'-methoxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5a);
[0055] 1-(2'-Hydroxy-4'-(4"-trifluoromethylbenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5c);
[0056] 1-(2'-Hydroxy-4'-(2"-bromo-4"-methoxybenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5d);
[0057] 1-(2'-Hydroxy-4'-(3"-bromobenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5e);
[0058] The present invention provides the use of compounds I / III (4) and II / V (5) of the above general formula in sterilization.
[0059] The compounds I / III (4) and II / V (5) of the above general formula provided by the present invention have high fungicidal activity, especially against one or more of potato dry rot pathogen (F.solani), apple rot pathogen (Cytospora sp.), apple anthracnose pathogen (C.gloeosporioides), tomato gray mold pathogen (B.cinerea), wheat fusarium rust pathogen (F.graminearum) and rice blast pathogen (M.grisea).
[0060] In particular, the acetophenone triazole derivatives of the present invention exhibited excellent fungicidal activity, wherein compound 4c exhibited inhibition rates of 90.44%, 62.40%, 96.23%, and 80.10% against tomato gray mold pathogen, wheat head blight pathogen, potato dry rot pathogen, and rice blast pathogen, respectively, at a concentration of 50.0 mg / L; and compound 5c exhibited inhibition rates of 90.56%, 73.09%, 93.64%, and 74.00% against these four fungi, respectively, at a concentration of 50.0 mg / L.
[0061] The invention provides application of acetophenone A in insecticide.
[0062] The acetophenone A provided by the invention has high insecticidal activity against one or more of aphids, armyworms, diamondback moths, and cotton bollworms.
[0063] The present invention provides the use of compounds I / III (4) and II / V (5) in insecticide.
[0064] The compounds of the general formula I / III (4) and II / V (5) of the present invention have good insecticidal activity, especially high insecticidal activity against one or more of aphids, armyworms, diamondback moths, and cotton bollworms.
[0065] In particular, the median lethal concentration (LC50) of acetophenone A against green peach aphid and oriental armyworm was 50 ) were 79.29 mg / L and 570 mg / L, respectively; the LC values of compound 5a for green peach aphid and oriental armyworm were 50 The LC values of compounds 5e and 5d against green peach aphid were 55.71 mg / L and 80 mg / L respectively. 50 They are 13.78mg / L and 14.37mg / L respectively.
[0066] The compounds of the general formula of the present invention can be used directly as insecticides and fungicides, or can be used with agriculturally acceptable carriers, or can be used in combination with other insecticides, acaricides and fungicides such as tebufenpyrad, chlorfenapyr, etoxazole, cypermethrin, etc. Some of these compositions show synergistic effects, while others show additive effects.
[0067] The following examples and biological test results can be used to further illustrate the present invention, but are not intended to limit the present invention.
[0068] Example 1: Synthesis of acetophenone triazole derivatives 4a and 5a
[0069]
[0070] Synthesis of intermediate 2a-1 (acetophenone A)
[0071] 2,4-Dihydroxytoluene (2-2, 1.0mmol) was added to a 25mL eggplant-shaped bottle, and then 8mL of boron trifluoride ether was added, followed by slow addition of acetic anhydride (1.2mmol). The system was stirred at 90°C until the reaction was complete, which took about 8h. The reaction system was poured into crushed ice and stirred for 10min, extracted with ethyl acetate (2×10mL), washed with H2O (2×10mL) and saturated sodium chloride (2×10mL), respectively, and the organic phases were combined and dried with anhydrous Na2SO4 for 10min. The solvent was removed by vacuum distillation, and the white solid natural product acetophenone A was obtained by purification by silica gel column chromatography (PE:EA=10:1). Yield 70%; NMR data: 1 H NMR (400MHz, CDCl3) δ12.53(s,1H),7.47(s,1H),6.34(s,1H),5.78(s,1H),2.55(s,3H),2.19(s,3H). 13 C NMR (100MHz,CDCl3)δ202.61,163.32,161.02,133.14,115.92,114.08,103.07,26.32,15.11; Mass spectral data: ESI-MS calcd for C9H9O3[MH] - 165.06.found:165.11.
[0072] Synthesis of intermediate 3a-1
[0073] Potassium carbonate (276 mg, 2 mmol) and iodomethane (74.7 μL, 1.2 mmol) were added to an acetone (3 mL) solution of 5-methyl-2,4-dihydroxyacetophenone (166 mg, 1 mmol), and the mixture was refluxed for 8 hours. The solvent in the system was removed by reduced pressure distillation, and the crude product was purified by silica gel column chromatography (PE:EA=15:1) to obtain compound 3a-1. White solid, yield 63%; melting point 94.0-95.0°C; NMR data: 1 H NMR (400MHz, CDCl3) δ12.68(s,1H),7.39(s,1H),6.33(s,1H),3.82(s,3H),2.51(s,3H),2.11(s,3H). 13 C NMR (100 MHz, CDCl3) δ 202.47, 164.38, 163.84, 131.74, 118.03, 112.96, 98.76, 55.64, 26.22, 15.58; mass spectral data: ESI-MS calcd for C 10 H 13 O3[M+H] +181.09.found:181.30.
[0074] Synthesis of acetophenone triazole derivative 4a
[0075] Ethyl acetate (15 mL) was added to the intermediate 3a-1 (10 mmol) and copper bromide (3.341 g, 15 mmol), and the mixture was refluxed at 65°C for 8 h. The cuprous bromide generated by the reaction was filtered, and the filtrate was washed with 5 mL of sodium bicarbonate for 3 times. The organic phases were combined and dried over anhydrous Na2SO4 for 10 min. The solvent in the reaction system was removed by vacuum distillation, and then purified by column chromatography (PE:DCM=5:1-1:1) to obtain the brominated product. Then isopropanol (30 mL) was added to the brominated product (10 mmol) and 4-amino-1,2,4-triazole (1.008 g, 12 mmol), and the mixture was heated at 80°C for 8 h. After the system was cooled, the mixture was evaporated to dryness under reduced pressure to obtain a residue, which was dissolved in dichloromethane (10 mL), stirred at 0°C for 30 min, and the precipitated solid was filtered and washed with dichloromethane (5 mL) to obtain the target compound 4a. White solid, yield 96%, melting point 222.7-223.2℃; NMR data: 1 H NMR (400MHz, DMSO-d6) δ11.35(s,1H),10.16(s,1H),9.30(s,1H),7.63(d,J= 1.0Hz,1H),7.16(s,2H),6.58(s,1H),5.99(s,2H),3.85(s,3H),2.08(s,3H). 13 C NMR (100 MHz, DMSO-d6) δ 189.50, 164.17, 161.13, 145.08, 144.18, 131.39, 118.08, 111.78, 98.88, 60.19, 55.94, 15.25. Mass spectral data: ESI-MS calcd for C 12 H 15 N4O3 + [M] + 263.11.found:263.33.
[0076] Synthesis of acetophenone triazole derivative 5a
[0077] At 0°C, concentrated hydrochloric acid (0.28 mL) was added to a mixed solution of compound 4a (1.56 mmol) and water (3.5 mL), and then 0.5 mL of sodium nitrite (0.12 g, 1.72 mmol) dissolved in water was added dropwise. The reaction mixture was stirred at room temperature for 1 h, and the precipitate was filtered and washed with 1 mL of water to obtain the target compound 5a. White solid, yield 89%, melting point 189.1-190.0°C; NMR data: 1 H NMR (400MHz, DMSO-d6) δ11.54(d,J=1.0Hz,1H),8.51(s,1H),8.00(s,1H),7.71(d,J=1.0Hz,1H),6.55(s,1H),5.83(s,2H),3.86(s,3H),2.10(s,2H). 13 C NMR (100 MHz, DMSO-d6) δ 194.32, 164.51, 162.21, 151.70, 146.21, 131.51, 118.26, 112.26, 99.41, 56.37, 56.20, 15.69. Mass spectral data: ESI-MS calcd for C 12 H 14 N3O3[M+H] + 248.11.found:248.34.
[0078] Compounds 4b to 4e were prepared by referring to the procedure of 4a; compounds 5b to 5e were prepared by referring to the procedure of 5a.
[0079] The characterization results of the obtained compounds are shown below:
[0080] 1H-1-(2'-(2"-hydroxy-4"-benzyloxy-5"-methyl)phenyl-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4b): white solid, yield 76%, melting point 207.8-209.5°C; 1 H NMR(400MHz,DMSO-d6)δ11.31(s,1H),10.22(s,1H),9.31(s,1H),7.67(s,1H),7. 50-7.32(m,5H),7.22(s,2H),6.69(s,1H),6.02(s,2H),5.21(s,2H),2.14(s,3H). 13C NMR(100MHz,DMSO-d6)δ191.61,189.58,163.02,160.92,145.00,144.07,136.32,13 1.10,128.57,128.02,127.41,118.35,112.42,100.59,69.59,60.49,15.29.ESI-MS calcd for C 18 H 19 N4O3 + [M] + 339.15.found:339.41.;
[0082] 1H-1-(2'-(2"-hydroxy-4"-(4"'-trifluoromethylbenzyl)oxy-5"-methyl)phenyl-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4c): white solid, yield 94%, melting point 233.7-234.2°C; 1 H NMR (400MHz, DMSO-d6) δ11.32(s,1H),10.21(s,1H),9.31(s,1H),7.79(d,J=8.0H z,2H),7.70(d,J=9.0Hz,3H),6.67(s,1H),6.01(s,2H),5.33(s,2H),2.17(s,3H). 13 C NMR(100MHz,DMSO-d6)δ189.58,162.65,160.82,145.48,144.08,141.23,131.20,128.45(q,J=31.6Hz), 127.80,125.45(q,J=3.8Hz),124.20(q,J=270.1Hz),117.77,112.65,99.78,68.70,60.14,15.24.ESI-MS calcd for C 19 H 18 F3N4O3 + [M] + 407.13.found:407.48.
[0083] 1H-1-(2'-(2"-hydroxy-4"-(2"'-bromo-4"'-methoxybenzyl)oxy-5"-methylphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4d): white solid, yield 89%, melting point 202.1-203.9°C; 1HNMR (400MHz, DMSO-d6) δ11.33(s,1H),10.16(s,1H),9.30(s,1H),7.67(s,1H),7.60(d,J=8.8Hz,1H),7.18(d,J=3. 2Hz,1H),7.16(s,2H),6.94(dd,J=8.8,3.1Hz,1H),6.68(s,1H),5.99(s,2H),5.15(s,2H),3.77(s,3H),2.15(s,3H). 13 C NMR(100MHz,DMSO-d6)δ189.82,163.04,161.20,159.27,145.49,144.57,136.61,133.95,1 31.67,118.77,116.26,115.89,113.30,113.07,100.45,70.16,60.81,56.59,15.71.ESI-MS calcd for C 19 H 20 BrN4O4 + [M] + 447.07.found:447.49.
[0084] 1H-1-(2'-(2"-hydroxy-4"-(3"'-bromobenzyl)oxy-5"-methylphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4e): white solid, yield 82%, melting point 221.0-222.8°C; 1 H NMR (400MHz, DMSO-d6) δ11.33(s,1H),10.19(s,1H),9.31(d,J=1.4Hz,1H),7.67(s,2H),7.55(dd,J=7.9,2.0Hz,1H), 7.50-7.47(m,1H),7.39(t,J=7.8Hz,1H),7.19(s,2H),6.65(d,J=1.5Hz,1H),6.01(s,2H),5.22(s,2H),2.15(s,3H). 13 C NMR(100MHz,DMSO-d6)δ189.56,162.71,160.82,145.02,144.09,139.17,131.18,130.8 6,130.82,129.99,126.35,122.18,118.30,112.61,100.15,68.21,60.17,14.91.ESI-MS calcd for C 18 H 18BrN4O3 + [M] + 417.06.found:417.46.
[0085] 1H-1-(2'-(2"-hydroxy-4"-benzyloxyphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4f): white solid, yield 78%, melting point 183.9-185.0°C; 1 H NMR (400MHz, DMSO-d6) δ11.43(s,1H),10.16(s,1H),9.30(s,1H),7.81(d,J=8.8Hz ,1H),7.48-7.34(m,5H),7.17(s,2H),6.70-6.65(m,2H),6.00(s,2H),5.19(s,2H). 13 C NMR(100MHz,DMSO-d6)δ189.40,164.88,162.03,145.00,144.10,136.18,13 2.06,128.55,128.14,127.84,113.79,108.20,102.03,69.66,60.40.ESI-MS calcd for C 17 H 17 N4O3 + [M] + 325.13.found:325.40.
[0086] 1-(2'-Hydroxy-4'-benzyloxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5b): white solid, yield 89%, melting point 143-144.1°C; 1 H NMR (400MHz, CDCl3) δ11.86(s,1H),8.22(s,1H),8.01(s,1H),7.42(s,1H),7.41-7.33(m,5H),6.47(s,1H),5.59(s,2H),5.09(s,2H),2.21(s,3H). 13 C NMR (100MHz, CDCl3) δ193.29,164.52,164.35,152.06,135.77,129.66,128 .77,128.35,127.25,119.67,110.60,100.44,70.32,53.85,15.94.ESI-MS calcd forC 18 H 18 N3O3[M+H] +324.14.found:324.45.
[0087] 1-(2'-Hydroxy-4'-(4"-trifluoromethylbenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5c): white solid, yield 82%, melting point 223.0-225.0°C; 1 H NMR (400MHz, DMSO-d6) δ11.31(s,1H),10.19(s,1H),9.30(s,1H),7.80(d,J=8.1Hz,2H),7.70(d,J =9.2Hz,3H),7.19(s,2H),6.66(s,1H),6.01(s,2H),5.34(s,2H),3.35(s,2H),2.19-2.15(m,3H). 13 C NMR(100MHz,DMSO-d6)δ189.60,162.66,160.85,145.02,144.09,141.24,131.22,128.46(q,J=31.74Hz),1 27.82,125.47(q,J=3.61Hz),124.22(q,J=270.3Hz),118.32,112.67,100.73,68.70,60.17,16.45.ESI-MS calcd for C 19 H 17 F3N3O3[M+H] + 392.12.found:391.51.
[0088] 1-(2'-Hydroxy-4'-(2"-bromo-4"-methoxybenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5d): white solid, yield 53%, melting point 229.7-231.2°C; 1 H NMR (400MHz, DMSO-d6) δ11.50(s,1H),8.50(d,J=1.7Hz,1H),8.00(d,J=1.7Hz,1H),7.74(s,1H),7.58(d,J=8.8Hz,1H) ,7.18(d,J=3.1Hz,1H),6.93(dd,J=8.8,3.1Hz,1H),6.65(s,1H),5.82(s,2H),5.15(s,2H),3.77(s,3H),2.15(s,3H). 13C NMR(100MHz,DMSO-d6)δ193.72,162.55,161.39,158.85,151.25,145.76,136.25,133.52,1 31.34,118.13,115.99,115.55,112.80,112.48,100.10,69.45,56.05,55.50,15.32.ESI-MS calcd for C 19 H 19 BrN3O4[M+H] + 432.06.found:432.48.
[0089] 1-(2'-Hydroxy-4'-(3"-bromobenzyl)oxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5e): white solid, yield 89%, melting point 150.0-151.6°C. 1 H NMR (400MHz, DMSO-d6) δ11.35(s,1H),10.22(s,1H),9.33(s,1H),7.69(s,2H),7.57(d,J=7.9Hz,1 H),7.50(d,J=7.6Hz,1H),7.43-7.39(m,1H),6.67(s,1H),6.02(s,2H),5.24(s,2H),2.16(s,3H). 13 C NMR(100MHz,DMSO-d6)δ189.58,162.73,160.86,145.06,144.12,139.19,131.20,130.8 9,130.85,130.02,126.96,121.81,118.32,112.64,100.21,68.63,60.23,14.43.ESI-MS calcd forC 18 H 17 BrN3O3[M+H] + 402.05.found:401.49.
[0090] 1-(2'-Hydroxy-4'-benzyloxyphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5f): white solid, yield 72%, melting point 133.4-135.3°C. 1H NMR(400MHz,DMSO-d6)δ11.91(s,1H),8.22(s,1H),8.02(s,1H),7.62(s,1H),7.43 -7.35(m,5H),6.61-6.58(m,1H),6.55(d,J=2.5Hz,1H),5.60(s,2H),5.11(s,2H).; 13 C NMR(100MHz,DMSO-d6)δ193.60,164.76,162.60,151.23,146.35,136.25,132.0 8,128.57,128.15,127.89,113.79,108.09,102.02,69.68,56.25.ESI-MScalcd for C 17 H 16 N3O3[M+H] + 310.12.found:310.46.
[0091] Example 2: Synthesis of acetophenone triazole derivatives 4g and 5g
[0092]
[0093] The synthesis of intermediate 2a-2 was completed by referring to the procedure of 2a-1.
[0094] Synthesis of intermediate 3b-1
[0095] Acetic acid (0.75 mol) was dissolved in dichloromethane (2 mL) solution, and compound 2a-2 (0.5 mmol) and 4-dimethylaminopyridine (6.01 mg, 0.05 mmol) were added. Then, the solution was cooled to 0°C and reacted for 15 min, and N,N-dicyclohexylcarbodiimide (123.79 mg, 0.6 mmol) was added, and reacted at room temperature for 4 h. The mixture was vacuum distilled and finally purified by silica gel column chromatography (PE:EA=20:1) to obtain compound 3b-1. Yellow solid, yield 75%, melting point 73.2-74.1°C; 1 H NMR (400MHz, CDCl3) δ12.42(s,1H),7.73(d,J=8.7Hz,1H),6.72(d,J=2.3Hz,1H),6.66(dd,J=8.7,2.2Hz,1H),2.59(s,3H),2.29(s,3H). 13C NMR (100MHz, CDCl3) δ203.58,168.47,163.89,156.62,131.96,117.70,112.90,111.10,26.64,21.14.ESI-MS calcd for C 10 H 11 O4[M+H] + 195.07.found:195.08.
[0096] Compound 4g was prepared by referring to the procedure of 4a; Compound 5g was prepared by referring to the procedure of 5a.
[0097] The characterization results of the obtained compounds are shown below:
[0098] 1H-1-(2'-(2"-Hydroxy-4"-acetoxyphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4 g): white solid, yield 63%, melting point 188.6-189.6°C. 1 H NMR (400MHz, DMSO-d6) δ11.58(s,1H),10.18(s,1H),9.31(s,1H),7.85(d,J=8.7Hz,1H),7 .20(s,1H),6.90(d,J=2.1Hz,1H),6.79(dd,J=8.7,2.1Hz,1H),6.03(s,2H),2.29(s,3H). 13 C NMR(100MHz,DMSO-d6)δ190.12,169.02,160.92,156.69,145.44,144.48,131.98,119.04,114.20,110.98,61.72,21.44.ESI-MS calcd for C 12 H 13 N4O4 + [M] + 277.09.found:277.32.
[0099] 1-(2'-Hydroxy-4'-acetoxy-phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5 g): white solid, yield 65%, melting point 169.8-171.2°C; 1H NMR (400 MHz, DMSO-d6) δ 11.48 (s, 1H), 8.51 (s, 1H), 8.01 (s, 1H), 7.86 (d, J = 8.7 Hz, 1H), 6.83 (d, J = 2.2 Hz, 1H), 6.77 (dd, J = 8.7, 2.2 Hz, 1H), 5.83 (s, 2H), 2.29 (s, 3H). 13C NMR(100MHz,DMSO-d6)δ193.70,169.05,160.92,156.38,151.65,146.12,132.01,119.12,114.01,110.99,58.07,21.42.ESI-MS calcd for C 12 H 12 N3O4[M+H] + 262.08.found:262.33.
[0100] Compounds 4h to 4i were prepared by referring to the procedure of 4g; compounds 5h to 5i were prepared by referring to the procedure of 5g.
[0101] The characterization results of the obtained compounds are shown below:
[0102] 1H-1-(2'-(2"-Hydroxy-4"-propionyloxyphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4h): white solid, yield 74%, melting point 195.6-196.6°C. 1 H NMR (400MHz, DMSO-d6) δ11.59(s,1H),10.11(d,J=1.6Hz,1H),9.30(s,1H),7.85(d,J=8.8Hz,1H),7.14(s,2H) ,6.87(d,J=2.2Hz,1H),6.79(dd,J=8.7,2.2Hz,1H),6.01(s,2H),2.63(q,J=7.5Hz,2H),1.13(t,J=7.5Hz,3H). 13 C NMR (100MHz, DMSO-d6) δ189.65,171.95,160.47,156.34,145.00,144.06,131.52,119.22,113.74,110.95,61.25,26.96,8.71.ESI-MS calcd for C 13 H 15 N4O4+ [M] + 291.11.found:291.32.
[0103] 1H-1-(2'-(2"-hydroxy-4"-acetoxy-5"-methylphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4i): white solid, yield 81.5%, melting point 225.0-226.5°C; 1 H NMR (400MHz, DMSO-d6) δ11.34(s,1H),10.19(s,1H),9.31(s,1H),7.71(s,1H),7.20(s,2H),6.85(s,1H),6.02(s,2H),2.33(s,3H),2.06(s,3H). 13 C NMR (100MHz, DMSO-d6) δ190.21,168.83,158.89,155.29,145.45,144.47,132.38,121.98,119.06,111.53,61.68,21.11,15.33.ESI-MS calcd forC 13 H 15 N4O4 + [M] + 291.11.found:291.32.
[0104] (2'-Hydroxy-4'-propionyloxy-phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5h): white solid, yield 73%, melting point 153.5-154.9°C. 1 H NMR (400MHz, DMSO-d6) δ11.43(s,1H),8.46(s,1H),7.96(s,1H),7.81(d,J=8.6Hz,1H),6.77(d,J= 2.3Hz, 1H), 6.72 (dd, J = 8.7, 2.2Hz, 1H), 5.78 (s, 2H), 2.57 (q, J = 7.5Hz, 2H), 1.07 (t, J = 7.5Hz, 3H). 13 C NMR (100MHz, DMSO-d6) δ193.70,172.44,160.96,156.48,151.62,146.11,132.01,119.05,114.01,110.96,93.29,58.07,27.41,9.18.ESI-MS calcd for C 13 H 14 N3O4[M+H] +276.10.found:276.35.
[0105] 1-(2'-Hydroxy-4'-acetoxy-5'-methylphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5i): white solid, yield 95%, melting point 204.9-206.4°C. 1 H NMR (400MHz, DMSO-d6) δ11.23(s,1H),8.52(s,1H),8.01(s,1H),7.74(s,1H),6.79(s,1H),5.82(s,2H),2.32(s,3H),2.07(s,3H). 13 C NMR (100MHz, DMSO-d6) δ193.79,168.84,158.89,154.97,151.62,132.51,121.76,119.17,111.49,58.02,21.09,15.34.ESI-MS calcd for C 13 H 14 N3O4[M+H] + 276.10.found:276.34.
[0106] Example 3: Synthesis of acetophenone triazole derivatives 4j and 5j
[0107]
[0108] Synthesis of intermediate 2b-1
[0109] Resorcinol (10mmol), iodobenzene (12mmol), cuprous iodide (0.1mmol), N,N-dimethylglycine (0.1mmol), potassium phosphate (20mmol) were added to 50mL of anhydrous dimethyl sulfoxide under the protection of nitrogen, reacted at 90°C for 24h, and then pure water was added, extracted with ethyl acetate (3×30mL), washed with H2O (2×30mL) and saturated NaCl (2×30mL), and the organic phases were combined and dried with anhydrous sodium sulfate for 10min. The solvent was removed by distillation under reduced pressure, and then purified by column chromatography (PE:EA=80:1) to obtain compound 2b-1.
[0110] The synthesis of intermediate 3c-1 was completed by referring to the procedure of 2a-1.
[0111] Compound 4j was prepared by referring to the procedure of 4a; Compound 5j was prepared by referring to the procedure of 5a.
[0112] The characterization results of the obtained compounds are shown below:
[0113] 1H-1-(2'-(2"-hydroxy-4"-phenoxyphenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4j): white solid, yield 74%, melting point 201.6-203.0°C; 1 H NMR (400MHz, DMSO-d6) δ11.40(s,1H),10.19(s,1H),9.30(s,1H),7.84(d,J=8.9Hz,1H),7.52-7.47(m,2H ),7.32-7.27(m,1H),7.19-7.15(m,2H),6.61(dd,J=8.9,2.4Hz,1H),6.53(d,J=2.4Hz,1H),5.98(s,2H). 13 CNMR(100MHz,DMSO-d6)δ188.95,164.00,161.48,154.20,144.95,144.02,132.47,130.45,125.34,120.63,115.68,109.35,104.13,61.01.ESI-MS calcd for C 16 H 15 N4O3 + [M] + 311.11.found:311.36.
[0114] 1-(2'-Hydroxy-4'-phenoxyphenyl)-2-(1H-1,2,4-triazolyl)ethanone (5j): white solid, yield 87%, melting point 149.4-151.3°C; 1 H NMR (400MHz, DMSO-d6) δ11.41(s,1H),8.59(s,1H),8.06(s,1H),7.86(d,J=8.9Hz,1H),7.49(t,J=7.8Hz,2H), 7.29(t,J=7.4Hz,1H),7.17(d,J=7.9Hz,2H),6.59(dd,J=8.9,2.4Hz,1H),6.49(d,J=2.3Hz,1H),5.80(s,2H). 13 C NMR (100MHz, DMSO-d6) δ192.55,163.69,161.66,154.30,150.75,145.56,132.48,130.42,125.26,120.59,115.72,109.14,104.30,57.37.ESI-MS calcd for C 16 H 14 N3O3[M+H] +296.11.found:296.42.
[0115] Compounds 4k to 4n were prepared by referring to the procedure of 4j; compounds 5k to 5n were prepared by referring to the procedure of 5j.
[0116] The characterization results of the obtained compounds are shown below:
[0117] 1H-1-(2'-(2"-hydroxy-4"-(3"'-methyl-4"'-bromophenoxy)phenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4k): white solid, yield 76%, melting point 194.9-196.3°C; 1 H NMR (400MHz, DMSO-d6) δ11.41(s,1H),10.15(d,J=45.3Hz,1H),9.29(d,J=4.5Hz,1H),7.83(d,J=9.0Hz,1H),7.68(dd,J=8.8,3.0Hz,1H), 7.26-7.11(m,3H),6.97(dd,J=8.5,3.0Hz,1H),6.63(dt,J=11.4,2.4Hz,1H),6.50(d,J=2.4Hz,1H),5.96(d,J=9.9Hz,2H),2.36(s,3).13C NMR(100MHz,DMSO-d6)δ188.93,163.62,161.42,153.64,145.00,144.08,139.77,133.7 2,132.54,123.19,120.11,119.87,115.96,109.46,104.34,61.07,22.49.ESI-MScalcd for C 17 H 16 BrN4O3 + [M] + 403.04.found:403.40.
[0118] 1H-1-(2'-(2"-hydroxy-4"-(3"'-nitrophenoxy)phenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4l): white solid, yield 84.5%, melting point 174.6-176.4°C; 1H NMR (400MHz, DMSO-d6) δ11.54(s,1H),10.26-10.08(m,1H),9.30(d,J=3.2Hz,1H),8.16-8.10(m,1H),7.93(t,J=2.3Hz,1H),7.88 (d,J=8.8Hz,1H),7.78(t,J=8.2Hz,1H),7.67(ddd,J=8.1,2.4,1.0Hz,1H),7.14(s,2H),6.77-6.60(m,2H),6.00(d,J=7.2Hz,2H). 13 C NMR(100MHz,DMSO-d6)δ189.64,161.90,155.72,149.42,145.47,144.55,133 .19,132.27,127.38,120.26,117.29,115.25,110.41,106.06,61.59.ESI-MS calcd for C 16 H 14 N5O5 + [M] + 356.10.found:356.41.
[0119] 1H-1-(2'-(2"-hydroxy-4"-(3"',4"'-difluorophenoxy)phenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4m): white solid, yield 82%, melting point 187.3-189.2°C; 1 H NMR (400MHz, DMSO-d6) δ11.45(s,1H),10.22(s,1H),9.30(s,1H),7.84(d,J=8.7Hz,1H),7.61-7.52(m,1 H),7.42(ddd,J=11.4,6.8,2.9Hz,1H),7.22(s,2H),7.09-7.02(m,1H),6.64-6.58(m,2H),6.00(s,2H). 13C NMR (100MHz, DMSO-d6) δ189.07,163.41,161.47,150.44(dd,J=8.8,2.7Hz),149.81(dd,J=248.0,14.0Hz),146.99(dd,J=243.1,12.5Hz) ,144.97,144.03,132.57,118.57(d,J=18.6Hz),117.44(dd,J=6.6,3.5Hz),116.15,110.84(d,J=19.5Hz),109.23,104.47,61.04.ESI-MS calcd for C 16 H 13 F2N4O3 + [M] + 347.10.found:347.40.
[0120] 1H-1-(2'-(2"-hydroxy-4"-(3"',4"'-dichlorophenoxy)phenyl)-2'-oxycarbonylethyl)-4-amino-1,2,4-triazolium bromide (4n): white solid, yield 91%, melting point 205.1-207.0℃; 1 H NMR (400MHz, DMSO-d6) δ11.52(s,1H),10.20(s,1H),9.31(s,1H),7.86(d,J=8.8Hz,1 H),7.53(s,1H),7.30(t,J=1.3Hz,2H),7.21(s,2H),6.70-6.64(m,2H),6.00(s,2H). 13 C NMR (100MHz, DMSO-d6) δ189.10,162.28,161.37,156.10,145.00,144.05,135.17,132.68,124.42,119.88,116.84,109.94,105.47,61.17.ESI-MS calcd for C 16 H 13 C l2 N4O3 + [M] + 379.04.found:379.40.
[0121] 2-(2'-Hydroxy-4'-(3"-methyl-4"-bromophenoxy)phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5k): white solid, yield 84%, melting point 150.2-151.3°C; 1H NMR (400MHz, CDCl3) δ11.77(s,1H),8.22(s,1H),8.01(s,1H),7.67(d,J=9.0Hz,1H),7.54(d,J=8.5Hz,1H),6.98(d,J= 2.9Hz, 1H), 6.80 (dd, J=8.6, 2.9Hz, 1H), 6.57 (dd, J=8.9, 2.4Hz, 1H), 6.41 (d, J=2.5Hz, 1H), 5.62 (s, 2H), 2.39 (s, 3H). 13 C NMR (100MHz, CDCl3) δ193.89,165.61,165.37,153.30,140.35,133.85,130.88 ,123.25,121.05,119.93,112.71,109.80,105.31,54.05,23.21.ESI-MScalcd for C 17 H 15 BrN3O3[M+H] + 388.03.found:388.45.
[0122] 2-(2'-Hydroxy-4'-(3"-nitrophenoxy)phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5l): white solid, yield 93%, melting point 162.7-164.1°C; 1 H NMR (400MHz, DMSO-d6) δ11.48(s,1H),8.52(s,1H),8.11(dd,J=8.3,2.2Hz,1H),8.01(s,1H),7.92(dd,J=4.7,2.5Hz,2 H),7.76(t,J=8.2Hz,1H),7.65(dd,J=8.2,2.5Hz,1H),6.69(dd,J=8.8,2.4Hz,1H),6.62(d,J=2.4Hz,1H),5.82(s,2H). 13 C NMR (100MHz, DMSO-d6) δ193.36,162.54,162.03,155.82,149.42,133.18,132.18,127.26,120.14,117.31,115.20,110.21,106.18,57.82.ESI-MS calcd forC 16 H 13 N4O5[M+H] + 341.09.found:341.47.
[0123] 2-(2'-Hydroxy-4'-(3",4"-difluorophenoxy)phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5m): white solid, yield 92%, melting point 188.6-190.3°C; 1 H NMR (400MHz, DMSO-d6) δ11.43(s,1H),8.50(s,1H),7.99(s,1H),7.87(d,J=8.8Hz,1H),7.60-7.50(m,1H),7.42(ddd,J=1 1.5, 6.8, 2.9Hz, 1H), 7.06 (ddd, J=8.7, 4.2, 2.5Hz, 1H), 6.61 (dd, J=8.9, 2.4Hz, 1H), 6.51 (d, J=2.4Hz, 1H), 5.79 (s, 2H). 13 C NMR (100MHz, DMSO-d6) δ192.84, 163.13, 161.62, 150.54 (dd, J=8.7, 2.9Hz), 149.81 (dd, J=248.0, 14.0Hz), 146.99 (dd, J=243.2, 12.5Hz),132.59,118.51(d,J=18.6Hz),117.36(dd,J=6.5,3.4Hz),116.17,110.80(d,J=19.6Hz),109.06,104.56,57.23.ESI-MS calcd for C 16 H 12 F2N3O3[M+H] + 332.09.found:331.45.
[0124] 2-(2'-Hydroxy-4'-(3",4"-dichlorophenoxy)phenyl)-2-(1H-1,2,4-triazolyl)ethanone (5n): white solid, yield 64%, melting point 172.0-174.0°C; 1 H NMR (400MHz, DMSO-d6) δ11.54(s,1H),10.14(s,1H),9.30(s,1H),7.86(d,J=8.9Hz,1H),7.55(t,J= 1.8Hz, 1H), 7.32 (d, J=1.8Hz, 2H), 6.69 (dd, J=8.8, 2.4Hz, 1H), 6.62 (d, J=2.4Hz, 1H), 5.98 (s, 2H). 13C NMR (101MHz, DMSO-d6) δ189.53,162.79,161.81,156.53,145.48,144.55,135.63,133.14,125.78,119.89,117.28,110.41,105.86,61.25.ESI-MS calcd for C 16 H 12 C l2 N3O3[M+H] + 364.03.found:363.45.
[0125] The compounds of the present invention can be prepared by the above method or a method similar to the above method, and the corresponding raw materials can be selected according to the different substituents and the different positions of the substituents.
[0126] Example 4: Antibacterial activity assay
[0127] The mycelium growth rate method was used to determine the inhibitory activity of the compounds against different plant-derived fungi. The specific method was as follows: the compound to be screened was prepared into a 10 mg / mL mother solution, 75 μL (50 ppm, the same below) was added to 20 mL of solid culture medium and quickly mixed. The test strains needed to be activated in advance, and a sufficient number of bacterial cakes were prepared with a 5 mm inner diameter puncher for standby use. The bacterial cakes were placed on the solidified culture medium with a sterile inoculation needle, with the mycelium side facing down, and gently pressed to make the bacterial cakes in close contact with the culture medium. Three bacterial cakes of the same pathogenic fungus were placed in each culture dish. The culture dishes with inoculated bacteria were placed in a constant temperature incubator at 26°C-28°C for dark culture. After 48 to 96 hours, the radial length of the fungal colony was measured with a ruler (cross method, average value).
[0128] The corresponding DMSO solvent system was used as the blank control, and carbendazim was used as the positive control. Inhibition rate (%) = inhibition rate (%) = (C–T) / (C–5mm) × 100%, C is the colony diameter (mm) of the blank control group, and T is the colony diameter (mm) of the treatment group or the positive control group.
[0129] Table 1. Fungicidal activity of acetophenone triazole derivatives 4(I) series
[0130]
[0131] Bc: B.cinerea; Cg: C.gloeosporioides; C.sp.: Cytospora sp; Fg: F.graminearum; Fs: F.solani; Mg: M.grisea; HMX: Hymexazol.
[0132] Table 2. Fungicidal activity of acetophenone triazole derivatives 5(II) series
[0133]
[0134] Bc: B.cinerea; Cg: C.gloeosporioides; C.sp.: Cytospora sp; Fg: F.graminearum; Fs: F.solani; Mg: M.grisea; HMX: Hymexazol.
[0135] The results in Table 1 and Table 2 show that the compounds I / III (4) and II / V (5) of the above general formula have high fungicidal activity, especially against one or more of potato dry rot pathogen (F.solani), apple rot pathogen (Cytospora sp.), apple anthracnose pathogen (C.gloeosporioides), tomato gray mold pathogen (B.cinerea), wheat fusarium rust pathogen (F.graminearum) and rice blast pathogen (M.grisea).
[0136] In particular, the acetophenone triazole derivatives of the present invention exhibited excellent fungicidal activity, wherein compound 4c exhibited inhibition rates of 90.44%, 62.40%, 96.23%, and 80.10% against tomato gray mold pathogen, wheat head blight pathogen, potato dry rot pathogen, and rice blast pathogen, respectively, at a concentration of 50.0 mg / L; and compound 5c exhibited inhibition rates of 90.56%, 73.09%, 93.64%, and 74.00% against these four fungi, respectively, at a concentration of 50.0 mg / L.
[0137] Example 5: Determination of insecticidal activity
[0138] The insecticidal activity was determined as follows:
[0139] Activity test of armyworm
[0140] The method of the activity test of the armyworm is to use the leaf immersion method proposed by the International Resistance Action Committee (IRAC). Weigh 2 mg of the drug sample on an analytical balance and put it in a 10 mL beaker, add 50 uL of acetone (analytical grade) to dissolve it, and add water to make a 500 ppm drug solution. Dip a leaf with a diameter of about 5-6 cm into the drug solution for 5-6 seconds, take it out, put it on absorbent paper to dry, put it in a designated culture dish, inoculate 10 3rd instar larvae, put it in an insect breeding room at 27±1℃, and observe the results after 2 days.
[0141] Activity test for aphids
[0142] The experimental method for testing the activity of aphids: leaf immersion method. After preparing the required concentration of the solution, immerse the leaves in the solution for 5-6 seconds, take them out, place them on absorbent paper to dry, place them in a designated culture dish, inoculate 20 aphids, put them in the insect breeding room, and check the results after 1 day of observation.
[0143] Activity test on Plutella xylostella
[0144] Activity test method for diamondback moth: leaf dipping method, after preparing the required concentration of liquid medicine, use straight ophthalmic forceps to dip the cabbage leaves for 2-3 seconds, and shake off the remaining liquid. 1 piece each time, 3 pieces for each sample. Place them on the treatment paper in the order of sample markings. After the liquid medicine dries, put it into a 10cm long straight tube with a mark, insert the 2nd instar diamondback moth larvae, and cover the tube mouth with gauze. Place the experimental treatment in a standard treatment room and check the results after 2 days of observation.
[0145] Activity test of cotton bollworm
[0146] The activity test method of cotton bollworm: feed mixing method, take 3mL from the prepared solution and add it to about 27g of freshly prepared feed to obtain the required concentration diluted ten times. After the agent is mixed, pour it evenly into a clean 24-well plate, cool it down, and then inoculate 24 third-instar cotton bollworms, and check the results after observing for 2-3 days.
[0147] Table 3. Fungicidal activity of acetophenone triazole derivatives
[0148]
[0149] Note: a ,48 hours activity data; b ,24-hour activity data; c ,2a-1:acetophenone A; - indicates not measured.
[0150] The results in Table 3 show that the compounds of the general formula I / III (4) and II / V (5) have good insecticidal activity, especially against one or more of aphids and armyworms.
[0151] In particular, the median lethal concentration (LC50) of acetophenone A against green peach aphid and oriental armyworm was 50 ) were 79.29 mg / L and 570 mg / L, respectively; the LC values of compound 5a for green peach aphid and oriental armyworm were 50 The LC values of compounds 5e and 5d against green peach aphid were 55.71 mg / L and 80 mg / L respectively. 50 They are 13.78mg / L and 14.37mg / L respectively.
[0152] Table 4. Insecticidal activity of acetophenone
[0153]
[0154] Note: a, ,48 hours activity data; b ,24-hour activity data;
[0155] The results in Table 4 show that acetophenone A has high insecticidal activity against one or more of aphids, armyworms, diamondback moths, and cotton bollworms.
[0156] The compounds of the general formula I / III (4) and II / V (5) of the present invention have good insecticidal activity, especially high insecticidal activity against one or more of aphids, armyworms, diamondback moths, and cotton bollworms.
[0157] In particular, the median lethal concentration (LC50) of acetophenone A against green peach aphid and oriental armyworm was 50 ) were 79.29 mg / L and 570 mg / L, respectively; the LC values of compound 5a for green peach aphid and oriental armyworm were 50 The LC values of compounds 5e and 5d against green peach aphid were 55.71 mg / L and 80 mg / L respectively. 50 They are 13.78mg / L and 14.37mg / L respectively.
[0158] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
[0159] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present disclosure will not further describe various possible combinations.
[0160] In addition, various embodiments of the present disclosure may be arbitrarily combined, and as long as they do not violate the concept of the present disclosure, they should also be regarded as the contents disclosed by the present disclosure.
Claims
1. A triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone, characterized in that: The derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof; Wherein, R in Formula I and Formula II 1 One selected from methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen; R in Formula I and Formula II 2 One selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms, methyl substituted by nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by oxygen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by sulfur-containing heterocycle containing 2-10 carbon atoms, and the aforementioned acyl groups with different substitutions; The substituents of the substituted phenyl and substituted benzyl are each independently selected from one or more of hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon, C1-C6 alkoxy, C1-C6 alkylamino, dioxymethylene and dioxyethylene; R in Formula I and Formula II 1 is hydrogen, R in Formula I and Formula II 2 The present invention is selected from substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, nitrogen-containing heterocycle containing 2-10 carbon atoms, oxygen-containing heterocycle containing 2-10 carbon atoms, sulfur-containing heterocycle containing 2-10 carbon atoms, methyl substituted by nitrogen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by oxygen-containing heterocycle containing 2-10 carbon atoms, methyl substituted by sulfur-containing heterocycle containing 2-10 carbon atoms and the aforementioned acyl groups with different substitutions; the substituents of the substituted phenyl and substituted benzyl are each independently selected from one or more of hydroxyl, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkylamino group, dioxymethylene group and dioxyethylene group.
2. The triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone according to claim 1, characterized in that The derivative is one of the compounds shown in the following formula:
3. A triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone, characterized in that: The derivative has a compound having a structure shown in the following general formula or a pharmaceutically acceptable salt thereof; Wherein, R in formula III and IV 1 One selected from methyl, isopropyl, cyclopropyl, isobutyl, sec-butyl and halogen; R 2 One or more selected from the group consisting of hydrogen, hydroxy, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 hydrocarbon group, C1-C6 alkylamino group, dioxymethylene and dioxyethylene.
4. Use of the triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone according to any one of claims 1 to 3 and 2,4-dihydroxy-5-methyl-acetophenone in preparing insecticides.
5. The use according to claim 4, characterized in that: The insecticide is used for preventing and controlling at least one of aphids, armyworms, diamondback moths and cotton bollworms.
6. Use of the triazole derivative of 2,4-dihydroxy-5-methyl-acetophenone according to any one of claims 1 to 3 for preparing a fungicide.
7. The use according to claim 6, characterized in that: The fungicide is used for preventing and controlling at least one of potato dry rot pathogen F.solani, apple rot pathogen Cytospora sp., apple anthracnose pathogen C.gloeosporioides, tomato gray mold pathogen B.cinerea, wheat fusarium rust pathogen F.graminearum and rice blast pathogen M.grisea.
Citation Information
Patent Citations
Acetophenone compound and preparation method thereof, and application of acetophenone compound to preparation of medicines used for treating cancer
CN110256252A
Synthesis of 2,4-dihydroxy-5-methyl acetophenone and derivative thereof and application of 2,4-dihydroxy-5-methyl acetophenone and derivative thereof as bactericides
CN103980102A
Substituted [1,2,4] triazole compounds
CN104955814A
Application and method for preventing or controlling plant diseases of diphenyl ether compound containing triazole structure and composition of diphenyl ether compound
CN115088722A
Azole compound and synthesis and pharmaceutical application thereof
CN116874430A
